Intravenous Thrombolysis in Patients Dependent on the Daily Help of Others before Stroke

Stroke

Volumn 47, Issue 2, 2016, Pages 450-456

  Gensicke, Henrik ^a   Strbian, Daniel ^b   Zinkstok, Sanne M ^c   Scheitz, Jan F ^d   Bill, Olivier ^e   Hametner, Christian ^f   Moulin, Solène ^g   Zini, Andrea ^h   Kägi, Georg ⁱ   Pezzini, Alessandro ^j   Padjen, Visnja ^k   Béjot, Yannick ^l   Corbiere, Sydney ^a   Zonneveld, Thomas P ^c   Seiffge, David J ^a   Roos, Yvo B ^c   Traenka, Christopher ^a   Putaala, Jukka ^b   Peters, Nils ^a   Bonati, Leo H ^a   Curtze, Sami ^b   Erdur, Hebun ^d   Sibolt, Gerli ^b   Koch, Peter ^d   Vandelli, Laura ^h   Ringleb, Peter ^f   Leys, Didier ^g   Cordonnier, Charlotte ^g   Michel, Patrik ^e   Nolte, Christian H ^d   Lyrer, Philippe A ^a   Tatlisumak, Turgut ^b,m   Nederkoorn, Paul J ^c   Engelter, Stefan T ^a,n   more..

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^f UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^g UNIV LILLE   (France)

^h AUSL Modena   (Italy)

ⁱ CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^j UNIVERSITY OF BRESCIA   (Italy)

^k CLINICAL CENTER OF SERBIA   (Serbia)

^l UNIVERSITÉ DE BOURGOGNE   (France)

^m SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

ⁿ Felix Platter Spital   (Switzerland)

more..

Author keywords

Infusions, intravenous; Intracranial hemorrhages; Outcome assessment (health care); Stroke; Survivors

Indexed keywords

FIBRINOLYTIC AGENT;

ADULT; AGED; ARTICLE; BONE DISEASE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANKIN SCALE; SURVIVOR; TREATMENT RESPONSE; CLINICAL TRIAL; COMPARATIVE STUDY; DAILY LIFE ACTIVITY; INDEPENDENT LIVING; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; MULTICENTER STUDY; REGISTER; STATISTICAL MODEL; STROKE; TREATMENT OUTCOME; VERY ELDERLY;

ACTIVITIES OF DAILY LIVING; ADMINISTRATION, INTRAVENOUS; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; INDEPENDENT LIVING; LOGISTIC MODELS; MALE; MIDDLE AGED; REGISTRIES; STROKE; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 84955323329     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.115.011674     Document Type: Article

References (19)

1. Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, et al; Stroke Thrombolysis Trialists' Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014;384:1929-1935. doi: 10.1016/S0140-6736(14)60584-5.
2. Bruno A, Shah N, Lin C, Close B, Hess DC, Davis K, et al. Improving modified Rankin Scale assessment with a simplified questionnaire. Stroke. 2010;41:1048-1050. doi: 10.1161/STROKEAHA.109.571562.
3. Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet. 2012;379:2352-2363.
4. Foell RB, Silver B, Merino JG, Wong EH, Demaerschalk BM, Poncha F, et al. Effects of thrombolysis for acute stroke in patients with preexisting disability. CMAJ. 2003;169:193-197.
5. Rudd M, Rodgers H, Curless R, Sudlow M, Huntley S, Madhava B, et al. Remote specialist assessment for intravenous thrombolysis of acute ischaemic stroke by telephone. Emerg Med J. 2012;29:704-708. doi: 10.1136/emermed-2011-200582.
6. Engelter ST, Soinne L, Ringleb P, Sarikaya H, Bordet R, Berrouschot J, et al. IV thrombolysis and statins. Neurology. 2011;77:888-895. doi: 10.1212/WNL.0b013e31822c9135.
7. Gensicke H, Zinkstok SM, Roos YB, Seiffge DJ, Ringleb P, Artto V, et al. IV thrombolysis and renal function. Neurology. 2013;81:1780-1788. doi: 10.1212/01.wnl.0000435550.83200.9e.
8. Zinkstok SM, Engelter ST, Gensicke H, Lyrer PA, Ringleb PA, Artto V, et al. Safety of thrombolysis in stroke mimics: results from a multicenter cohort study. Stroke. 2013;44:1080-1084. doi: 10.1161/STROKEAHA.111.000126.
9. Scheitz JF, Seiffge DJ, Tütüncü S, Gensicke H, Audebert HJ, Bonati LH, et al. Dose-related effects of statins on symptomatic intracerebral hemorrhage and outcome after thrombolysis for ischemic stroke. Stroke. 2014;45:509-514. doi: 10.1161/STROKEAHA.113.002751.
10. Lyden P, Brott T, Tilley B, Welch KM, Mascha EJ, Levine S, et al. Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group. Stroke. 1994;25:2220-2226.
11. Fluri F, Hatz F, Voss B, Lyrer PA, Engelter ST. Restenosis after carotid endarterectomy: significance of newly acquired risk factors. Eur J Neurol. 2010;17:493-498. doi: 10.1111/j.1468-1331.2009.02858.x.
12. Karlinski M, Kobayashi A, Czlonkowska A, Mikulik R, Vaclavik D, Brozman M, et al; Safe Implementation of Treatments in Stroke-Eastern Europe (SITS-EAST) Investigators. Role of preexisting disability in patients treated with intravenous thrombolysis for ischemic stroke. Stroke. 2014;45:770-775. doi: 10.1161/STROKEAHA.113.003744.
13. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet. 1998;352:1245-1251.
14. Kammersgaard LP, Jørgensen HS, Reith J, Nakayama H, Pedersen PM, Olsen TS; Copenhagen Stroke Study. Short-and long-term prognosis for very old stroke patients. The Copenhagen Stroke Study. Age Ageing. 2004;33:149-154. doi: 10.1093/ageing/afh052.
15. Alshekhlee A, Li CC, Chuang SY, Vora N, Edgell RC, Kitchener JM, et al. Does dementia increase risk of thrombolysis?: a case-control study. Neurology. 2011;76:1575-1580. doi: 10.1212/WNL.0b013e3182190d37.
16. Saposnik G, Kapral MK, Cote R, Rochon PA, Wang J, Raptis S, et al. Is pre-existing dementia an independent predictor of outcome after stroke? A propensity score-matched analysis. J Neurol. 2012;259:2366-2375. doi: 10.1007/s00415-012-6508-4.
17. Suarez JI, Sunshine JL, Tarr R, Zaidat O, Selman WR, Kernich C, et al. Predictors of clinical improvement, angiographic recanalization, and intracranial hemorrhage after intra-arterial thrombolysis for acute ischemic stroke. Stroke. 1999;30:2094-2100.
18. Mishra NK, Ahmed N, Davalos A, Iversen HK, Melo T, Soinne L, et al; SITS and VISTA Collaborators. Thrombolysis outcomes in acute ischemic stroke patients with prior stroke and diabetes mellitus. Neurology. 2011;77:1866-1872. doi: 10.1212/WNL.0b013e318238ee42.
19. Fearon P, McArthur KS, Garrity K, Graham LJ, McGroarty G, Vincent S, et al. Prestroke modified rankin stroke scale has moderate interobserver reliability and validity in an acute stroke setting. Stroke. 2012;43:3184-3188. doi: 10.1161/STROKEAHA.112.670422.